Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers

Cancer Science

Volumn 104, Issue 1, 2013, Pages 135-141

  Shen, Hong ^a   Huang, Jinlin ^a   Pei, Haiping ^a   Zeng, Shan ^a   Tao, Yiming ^a   Shen, Liangfang ^a   Zeng, Liang ^b   Zhu, Hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 27; PARAFFIN;

ARTICLE; CARCINOGENESIS; CHINA; COLON CANCER; ENERGY METABOLISM; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN UNFOLDING; PROTEOMICS; STAINING; TISSUE MICROARRAY; TUMOR GROWTH; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

CHINA; COLONIC NEOPLASMS; ENERGY METABOLISM; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; OXIDATIVE STRESS; PROTEIN FOLDING; PROTEOMICS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872272104     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12029     Document Type: Article

References (44)

1. National Cancer Institute: SEER Stat Fact Sheets: Colon and Rectum. Bethesda, MD. [Cited 6 Jul 2011.] Available from URL: http://seer.cancer.gov/statfacts/html/colorect.html.
2. Butcher D, Hassanein K, Dudgeon M, Rhodes J, Holmes FF. Female gender is a major determinant of changing subsite distribution of colorectal cancer with age. Cancer 1985; 56: 714-16.
3. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001; 96: 882-6.
4. Konopke R, Distler M, Ludwig S, Kersting S. Location of liver metastases reflects the site of the primary colorectal carcinoma. Scand J Gastroenterol 2008; 43: 192-5.
5. Kim DH, Shin MH, Ahn YO. Incidence pattern of colorectal cancer in Korea by subsite of origin. J Korean Med Sci 2000; 15: 675-81.
6. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, Hillon P. Adenoma-carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer 1992; 69: 883-8.
7. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996; 78: 1149-67.
8. Pei H, Zhu H, Zeng S et al. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 2007; 6: 2495-501.
9. Zhu H, Pei HP, Zeng S et al. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. J Proteome Res 2009; 8: 3969-76.
10. Shen LF, Chen J, Zeng S et al. The superparamagnetic nanoparticles carrying the E1A gene enhance the radiosensitivity of human cervical carcinoma in nude mice. Mol Cancer Ther 2010; 9: 2123-30.
11. Ilyas M, Hao XP, Wilkinson K et al. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer. Gut 1998; 43: 383-7.
12. Carr KM, Rosenblatt K, Petricoin EF, Liotta LA. Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Hum Genomics 2004; 1: 134-40.
13. Albrethsen J, Knol JC, Piersma SR et al. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol Cell Proteomics 2010; 9: 988-1005.
14. Beck HC, Petersen J, Nielsen SJ et al. Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat. Electrophoresis 2010; 31: 2714-21.
15. Rho JH, Qin S, Wang JY, Roehrl MH. Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res 2008; 7: 2959-72.
16. Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 2010; 37: 707-18.
17. Iwatani Y, Shimada Y, Seima Y, Yamazaki T, Miyazaki N. The biological and clinicopathological characteristics of right-sided colon cancer. Oncol Rep 2000; 7: 991-4.
18. Kim YW, Lee S, Park JH, Yoon TY, Park YK, Yang MH. An immunohistochemical study of the expression of p53 protein in colon cancer. J Korean Med Sci 1995; 10: 176-82.
19. Szymczyk P, Jakubik J, Krajewska WM, Dus D, Berner J, Kilianska ZM. Colorectal cancer-associated nuclear antigen. Biochim Biophys Acta 2000; 1501: 162-70.
20. Regoly-Merei A, Bereczky M, Arato G et al. [Nutritional and antioxidant status of colorectal cancer patients]. Orv Hetil 2007; 148: 1505-9.
21. Gonzalez V, Pal R, Narayan M. The oxidoreductase behavior of protein disulfide isomerase impedes fold maturation of endoplasmic reticulum-processed proteins in the pivotal structure-coupled step of oxidative folding: implications for subcellular protein trafficking. Biochemistry 2010; 49: 6282-9.
22. Ryu JW, Kim HJ, Lee YS et al. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003; 18: 505-9.
23. Goplen D, Wang J, Enger PO et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 2006; 66: 9895-902.
24. Stierum R, Gaspari M, Dommels Y et al. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta 2003; 1650: 73-91.
25. Wang Y, Ma Y, Lu B, Xu E, Huang Q, Lai M. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp Biol Med (Maywood). 2007; 232: 1152-9.
26. Osman C, Merkwirth C, Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009; 122: 3823-30.
27. Chen D, Chen F, Lu X et al. Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology. Int J Oncol 2010; 37: 355-65.
28. Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol 2006; 210: 351-7.
29. Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 2010; 102: 932-41.
30. Liao SH, Zhao XY, Han YH et al. Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells. Proteomics 2009; 9: 3901-12.
31. Borges JC, Ramos CH. Protein folding assisted by chaperones. Protein Pept Lett 2005; 12: 257-61.
32. Cappello F, Bellafiore M, Palma A et al. 60 KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur J Histochem 2003; 47: 105-10.
33. Lazaris AC, Theodoropoulos GE, Davaris PS et al. Heat shock protein 70 and HLA-DR molecules tissue expression Prognostic implications in colorectal cancer. Dis Colon Rectum 1995; 38: 739-45.
34. Zhang WL, Gao XQ, Han JX, Wang GQ, Yue LT. Expressions of heat shock protein (HSP) family HSP 60, 70 and 90 alpha in colorectal cancer tissues and their correlations to pathohistological characteristics. Ai Zheng 2009; 28: 612-18.
35. Cappello F, David S, Rappa F et al. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 2005; 5: 139.
36. Pfister K, Radons J, Busch R et al. Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 2007; 110: 926-35.
37. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67: 3496-9.
38. Garrido C, Fromentin A, Bonnotte B et al. Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. Cancer Res 1998; 58: 5495-9.
39. Cuezva JM, Krajewska M, de Heredia ML et al. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 2002; 62: 6674-81.
40. Shin YK, Yoo BC, Chang HJ et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 2005; 65: 3162-70.
41. Ogawa K, Utsunomiya T, Mimori K et al. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br J Cancer 2004; 91: 282-6.
42. Shuda M, Kondoh N, Tanaka K et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 2000; 20: 2489-94.
43. Tachibana M, Ohkura Y, Kobayashi Y et al. Expression of apolipoprotein A1 in colonic adenocarcinoma. Anticancer Res 2003; 23: 4161-7.
44. Fentz AK, Sporl M, Spangenberg J et al. Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels. Proteomics Clin Appl 2007; 1: 536-44.